News FDA approves smartwatch for epilepsy monitoring A new smart watch which monitors for the most dangerous kinds of epileptic seizures, known as "grand mal" or "generalised tonic-clonic" seizures, has been approved by the FDA.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.